CTMX CytomX Therapeutics, Inc.
Healthcare · Pharmaceutical Preparations · Market cap: $444.5M
–
Bought and sold by quarter, last 5 years
Open-market purchases and sales by this company's insiders, in dollars, last 5 years
| Quarter | Bought | Sold |
|---|---|---|
| 2022-Q1 | $0 | $0 |
| 2022-Q2 | $0 | $0 |
| 2022-Q3 | $0 | $59.3K |
| 2022-Q4 | $0 | $0 |
| 2023-Q1 | $7.8K | $33.3K |
| 2023-Q2 | $0 | $0 |
| 2023-Q3 | $0 | $36.8K |
| 2023-Q4 | $0 | $38.3K |
| 2024-Q1 | $0 | $99.9K |
| 2024-Q2 | $0 | $0 |
| 2024-Q3 | $0 | $35.0K |
| 2024-Q4 | $0 | $0 |
| 2025-Q1 | $0 | $48.0K |
| 2025-Q2 | $0 | $220.1K |
| 2025-Q3 | $0 | $0 |
| 2025-Q4 | $0 | $924.0K |
| 2026-Q1 | $0 | $1.2M |
| 2026-Q2 | $0 | $5.0K |
| 2026-Q3 | $0 | $0 |
| 2026-Q4 | $0 | $0 |
Bought$7.8K1 buy day
Sold$2.7M46 sell days
Net insider flow-$2.7Mnet selling · 5 years
Latest trade2026-06-15Ogden Christopher
| Date | Side | Insider | Role | Shares | Avg price | Value | Trades |
|---|---|---|---|---|---|---|---|
| 2026-06-15 | Sell | Ogden Christopher | CFO | 1,624 | $3.05 | $5.0K | 1 |
| 2026-03-17 | Sell | McCarthy Sean A. | CEO | 118,969 | $6.42 | $763.8K | 1 |
| 2026-03-17 | Sell | BELVIN MARCIA | Other C-suite | 31,492 | $6.42 | $202.2K | 1 |
| 2026-03-17 | Sell | Chu Yu-Waye | Other C-suite | 21,279 | $6.42 | $136.6K | 1 |
| 2026-03-17 | Sell | Ogden Christopher | CFO | 19,323 | $6.42 | $124.1K | 1 |
| 2025-11-06 | Sell | McCarthy Sean A. | CEO | 203,586 | $4.54 | $924.0K | 2 |
| 2025-06-16 | Sell | McCarthy Sean A. | CEO | 55,511 | $2.69 | $149.3K | 1 |
| 2025-06-16 | Sell | BELVIN MARCIA | Other C-suite | 13,884 | $2.69 | $37.3K | 1 |
| 2025-06-16 | Sell | Ogden Christopher | CFO | 10,614 | $2.69 | $28.6K | 1 |
| 2025-06-13 | Sell | Ogden Christopher | CFO | 1,641 | $2.95 | $4.8K | 1 |
| 2025-03-18 | Sell | McCarthy Sean A. | CEO | 37,656 | $0.60 | $22.6K | 1 |
| 2025-03-18 | Sell | BELVIN MARCIA | Other C-suite | 19,512 | $0.60 | $11.7K | 1 |
| 2025-03-18 | Sell | ROWLAND LLOYD A | General counsel | 10,203 | $0.60 | $6.1K | 1 |
| 2025-03-18 | Sell | Ogden Christopher | CFO | 8,551 | $0.60 | $5.1K | 1 |
| 2025-03-18 | Sell | Chu Yu-Waye | Other C-suite | 4,025 | $0.60 | $2.4K | 1 |
| 2024-08-20 | Sell | McCarthy Sean A. | CEO | 13,898 | $1.23 | $17.1K | 1 |
| 2024-08-20 | Sell | ROWLAND LLOYD A | General counsel | 4,181 | $1.23 | $5.1K | 1 |
| 2024-08-20 | Sell | BELVIN MARCIA | Other C-suite | 4,181 | $1.23 | $5.1K | 1 |
| 2024-08-20 | Sell | Landau Jeffrey B | Other C-suite | 4,181 | $1.23 | $5.1K | 1 |
| 2024-08-20 | Sell | Ogden Christopher | CFO | 1,984 | $1.23 | $2.4K | 1 |
| 2024-03-19 | Sell | McCarthy Sean A. | CEO | 20,223 | $2.09 | $42.3K | 1 |
| 2024-03-19 | Sell | BELVIN MARCIA | Other C-suite | 12,795 | $2.09 | $26.7K | 1 |
| 2024-03-19 | Sell | Landau Jeffrey B | Other C-suite | 6,562 | $2.09 | $13.7K | 1 |
| 2024-03-19 | Sell | ROWLAND LLOYD A | General counsel | 5,268 | $2.09 | $11.0K | 1 |
| 2024-03-19 | Sell | Ogden Christopher | EVP / SVP | 2,971 | $2.09 | $6.2K | 1 |
| 2023-12-20 | Sell | McCarthy Sean A. | CEO | 13,551 | $1.38 | $18.7K | 1 |
| 2023-12-20 | Sell | Landau Jeffrey B | Other C-suite | 4,077 | $1.38 | $5.6K | 1 |
| 2023-12-20 | Sell | ROWLAND LLOYD A | General counsel | 4,077 | $1.38 | $5.6K | 1 |
| 2023-12-20 | Sell | BELVIN MARCIA | Other C-suite | 4,077 | $1.38 | $5.6K | 1 |
| 2023-12-20 | Sell | Ogden Christopher | EVP / SVP | 1,990 | $1.38 | $2.7K | 1 |
| 2023-09-22 | Sell | McCarthy Sean A. | CEO | 14,601 | $1.30 | $19.0K | 1 |
| 2023-09-22 | Sell | ROWLAND LLOYD A | General counsel | 5,486 | $1.30 | $7.1K | 1 |
| 2023-09-22 | Sell | Landau Jeffrey B | Other C-suite | 4,119 | $1.30 | $5.4K | 1 |
| 2023-09-22 | Sell | BELVIN MARCIA | Other C-suite | 4,119 | $1.30 | $5.4K | 1 |
| 2023-03-29 | Buy | Jones Elaine V | Director | 5,000 | $1.55 | $7.8K | 1 |
| 2023-03-16 | Sell | McCarthy Sean A. | CEO | 7,121 | $1.88 | $13.4K | 1 |
| 2023-03-16 | Sell | Peterson Amy C. | Other C-suite | 4,257 | $1.98 | $8.4K | 1 |
| 2023-03-16 | Sell | ROWLAND LLOYD A | General counsel | 2,037 | $1.98 | $4.0K | 1 |
| 2023-03-16 | Sell | Campoy Carlos | CFO | 1,748 | $1.98 | $3.5K | 1 |
| 2023-03-16 | Sell | Landau Jeffrey B | CFO | 1,477 | $1.98 | $2.9K | 1 |
| 2023-03-16 | Sell | Ogden Christopher | EVP / SVP | 516 | $1.98 | $1.0K | 1 |
| 2022-07-20 | Sell | McCarthy Sean A. | CEO | 14,911 | $1.42 | $21.2K | 1 |
| 2022-07-20 | Sell | Peterson Amy C. | Other C-suite | 7,463 | $1.42 | $10.6K | 1 |
| 2022-07-20 | Sell | HANNAH ALISON L. | Other C-suite | 5,602 | $1.42 | $8.0K | 1 |
| 2022-07-20 | Sell | ROWLAND LLOYD A | General counsel | 5,602 | $1.42 | $8.0K | 1 |
| 2022-07-20 | Sell | Landau Jeffrey B | Other C-suite | 4,206 | $1.42 | $6.0K | 1 |
| 2022-07-20 | Sell | Campoy Carlos | CFO | 3,949 | $1.42 | $5.6K | 1 |
Who the insiders are, last 5 years
Everyone who bought or sold this company's shares on the open market in the last 5 years, biggest first.
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| McCarthy Sean A. | CEO | $0 | $2.0M | 2026-03-17 |
| BELVIN MARCIA | Other C-suite | $0 | $294.1K | 2026-03-17 |
| Ogden Christopher | CFO | $0 | $179.9K | 2026-06-15 |
| Chu Yu-Waye | Other C-suite | $0 | $139.0K | 2026-03-17 |
| ROWLAND LLOYD A | General counsel | $0 | $47.0K | 2025-03-18 |
| Landau Jeffrey B | Other C-suite | $0 | $38.7K | 2024-08-20 |
| Peterson Amy C. | Other C-suite | $0 | $19.0K | 2023-03-16 |
| Campoy Carlos | CFO | $0 | $9.1K | 2023-03-16 |
| HANNAH ALISON L. | Other C-suite | $0 | $8.0K | 2022-07-20 |
| Jones Elaine V | Director | $7.8K | $0 | 2023-03-29 |
Past buying clusters
A cluster is a run of purchases by three or more insiders. Returns are the stock's return minus its benchmark's (IWM for small companies, SPY otherwise), from the first open after the run became a cluster. Past results, not a forecast.
No buying cluster has formed at this company.
Yahoo Finance data, delayed, loaded through this server. Informational only; not investment advice.